Literature DB >> 2146089

Renal function studies using 99mTc-MAG3: pharmacokinetics and slope clearance determination.

B Bubeck1, W Brandau, E Weber, S Pomer, P Georgi, K zum Winkel.   

Abstract

Mesh：

Substances：

Year:  1990        PMID： 2146089     DOI： 10.1159/000418153

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN： 0302-5144            Impact factor:   1.580


× No keyword cloud information.
  3 in total

1.  A new principle to normalize plasma concentrations allowing single-sample clearance determinations in both children and adults.

Authors:  B Bubeck; R Piepenburg; U Grethe; B Ehrig; K Hahn
Journal:  Eur J Nucl Med       Date:  1992

2.  Early side effects and first results of radioligand therapy with (177)Lu-DKFZ-617 PSMA of castrate-resistant metastatic prostate cancer: a two-centre study.

Authors:  Hojjat Ahmadzadehfar; Kambiz Rahbar; Stefan Kürpig; Martin Bögemann; Michael Claesener; Elisabeth Eppard; Florian Gärtner; Sebastian Rogenhofer; Michael Schäfers; Markus Essler
Journal:  EJNMMI Res       Date:  2015-06-20       Impact factor: 3.138

3.  Therapeutic response and side effects of repeated radioligand therapy with 177Lu-PSMA-DKFZ-617 of castrate-resistant metastatic prostate cancer.

Authors:  Hojjat Ahmadzadehfar; Elisabeth Eppard; Stefan Kürpig; Rolf Fimmers; Anna Yordanova; Carl Diedrich Schlenkhoff; Florian Gärtner; Sebastian Rogenhofer; Markus Essler
Journal:  Oncotarget       Date:  2016-03-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.